|
ZKSCAN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64501745558709E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.56141807553468E-14 |
| Normal-vs-Stage2 |
3.23600002349878E-09 |
| Normal-vs-Stage3 |
1.62736490949555E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.732000E-02 |
| Stage1-vs-Stage3 |
1.382350E-01 |
| Stage1-vs-Stage4 |
1.800180E-04 |
| Stage2-vs-Stage3 |
1.165640E-02 |
| Stage2-vs-Stage4 |
1.390040E-04 |
| Stage3-vs-Stage4 |
3.557800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64046554118613E-12 |
| Normal-vs-AfricanAmerican |
1.64209978947838E-10 |
| Normal-vs-Asian |
1.31320510021737E-11 |
| Caucasian-vs-AfricanAmerican |
8.762000E-01 |
| Caucasian-vs-Asian |
5.673000E-01 |
| AfricanAmerican-vs-Asian |
6.249600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23154827949656E-14 |
| Normal-vs-Female |
1.64845914696343E-12 |
| Male-vs-Female |
7.507200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.8199664825479E-14 |
| Normal-vs-Age(41-60Yrs) |
1.67643676718399E-14 |
| Normal-vs-Age(61-80Yrs) |
1.47215573065296E-13 |
| Normal-vs-Age(81-100Yrs) |
4.24730000000428E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.402400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.059200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.064400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.813400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.689000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.802800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.140030E-03 |
| Classical-VS-Follicular |
8.420600E-01 |
| Classical-VS-Other |
3.881200E-01 |
| Classical-VS-Normal |
1.84330328778515E-12 |
| Tall-VS-Follicular |
5.975800E-03 |
| Tall-VS-Other |
5.748600E-01 |
| Tall-VS-Normal |
2.22044604925031E-16 |
| Follicular-VS-Other |
4.438800E-01 |
| Follicular-VS-Normal |
1.66067160023431E-12 |
| Other-VS-Normal |
1.164560E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1183055309848E-13 |
| Normal-vs-N1 |
1.62481139653892E-12 |
| N0-vs-N1 |
4.775100E-03 |
|
|
